| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.48B | 1.49B | 1.71B | 1.82B | 1.35B | 1.29B |
| Gross Profit | 109.79M | 104.40M | 140.26M | 156.16M | 104.60M | 118.03M |
| EBITDA | 83.55M | 77.97M | 86.07M | 123.42M | 75.80M | 106.24M |
| Net Income | 23.92M | 16.98M | 20.51M | 55.83M | 31.25M | 56.79M |
Balance Sheet | ||||||
| Total Assets | 1.08B | 1.08B | 1.21B | 1.26B | 1.04B | 814.06M |
| Cash, Cash Equivalents and Short-Term Investments | 75.70M | 88.78M | 77.97M | 42.95M | 49.85M | 106.44M |
| Total Debt | 137.53M | 147.05M | 294.84M | 281.45M | 180.58M | 66.21M |
| Total Liabilities | 500.78M | 507.43M | 667.46M | 735.73M | 581.80M | 372.09M |
| Stockholders Equity | 577.14M | 569.88M | 540.46M | 523.99M | 453.97M | 441.97M |
Cash Flow | ||||||
| Free Cash Flow | 115.81M | 150.26M | 27.14M | -104.49M | -157.89M | 90.74M |
| Operating Cash Flow | 146.53M | 183.94M | 73.22M | -13.80M | -83.18M | 130.09M |
| Investing Cash Flow | -26.13M | -14.70M | -46.52M | -90.47M | -74.80M | -38.80M |
| Financing Cash Flow | -121.89M | -160.87M | 8.97M | 99.18M | 103.74M | -53.08M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
87 Outperform | $158.50M | 17.15 | 18.65% | 3.85% | 4.90% | 31.13% | |
69 Neutral | $1.22B | 32.87 | 8.33% | 0.35% | 15.93% | 12.72% | |
64 Neutral | $106.55M | 62.88 | 1.26% | ― | 12.94% | -81.09% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | $707.03M | 32.02 | 4.25% | ― | -10.46% | 88.34% | |
54 Neutral | $339.31M | -7.33 | -1421.39% | ― | 7.06% | 12.25% | |
47 Neutral | $220.55M | -163.32 | -0.34% | ― | ― | -100.27% |
On January 8, 2026, Kimball Electronics announced it will hold a ribbon-cutting ceremony on February 6, 2026, to mark the opening of its new advanced medical manufacturing and innovation facility in Indianapolis, which will serve the medical and life sciences industries and is expected to expand the company’s manufacturing capacity and local community presence. The company also revealed plans to rebrand as Kimball Solutions, Inc., beginning with a phased global rollout in July 2026 subject to necessary approvals, a move that reflects its broadened capabilities and solutions-driven strategy and is intended to reinforce its long-term commitment to innovation, comprehensive customer solutions, and growth in the EMS and CMO markets.
The most recent analyst rating on (KE) stock is a Buy with a $32.00 price target. To see the full list of analyst forecasts on Kimball Electronics stock, see the KE Stock Forecast page.
At the Annual Meeting of Share Owners held on November 14, 2025, Kimball Electronics‘ Share Owners voted on several key items. The Share Owners re-elected Class II director nominees Michele A. M. Holcomb, Tom G. Vadaketh, and Holly A. Van Deursen with a high percentage of votes in favor. Deloitte & Touche, LLP was ratified as the independent registered public accounting firm for fiscal year 2026, and the compensation for the company’s Named Executive Officers was approved on a non-binding, advisory basis. Additionally, the Board maintained its Committee and Chairperson appointments, with Robert J. Phillippy continuing as Chairperson.
The most recent analyst rating on (KE) stock is a Buy with a $32.00 price target. To see the full list of analyst forecasts on Kimball Electronics stock, see the KE Stock Forecast page.